AlphaFold predicted structure
MARS2 · Q96GW9

Mean pLDDT
89.3/ 100
Confident
593 residues
Confidence breakdown
- Very high(≥ 90)80%
- Confident(70–90)11%
- Low(50–70)1%
- Very low(< 50)9%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
methionyl-tRNA synthetase 2, mitochondrial
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Ataxia and cerebellar anomalies - narrow panel
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
BIALLELIC, autosomal or pseudoautosomalHereditary ataxia
BIALLELIC, autosomal or pseudoautosomalHereditary ataxia with onset in adulthood
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomal+5 more panels — install the extension to see the full list inline on any page.
spastic ataxia 3
Autosomal recessive spastic ataxia with leukoencephalopathy
combined oxidative phosphorylation defect type 25
neurodegenerative disease
inborn mitochondrial metabolism disorder
mitochondrial disease
lysosomal storage disease
cervical carcinoma
obesity disorder
overnutrition
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
MARS2 · Q96GW9

Mean pLDDT
89.3/ 100
Confident
593 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0